PaperA thromboxane synthetase inhibitor reorients endoperoxide metabolism in whole blood towards prostacyclin and prostaglandin E2
References (14)
- et al.
Characterization of prostacyclin synthesis in cultured human arterial smooth muscle cells, venous endothelial cells and skin fibroblasts
Cell
(1979) - et al.
Administration to man of UK-37,248-01, a selective inhibitor of thromboxane synthetase
Lancet
(1981) - et al.
Thromboxane synthetase inhibition as antithrombotic strategy
Lancet
(1981) - et al.
The chemical structure of prostaglandin X (prostacyclin)
Prostaglandins
(1976) - et al.
Variables associated with radioimmunoassay of prostaglandins in plasma
Prostaglandins
(1981) - et al.
The use of immobilized ligands and 125I protein A for immunoassays of thromboxane B2, prostaglandin D2, 13,14-dihydro-prostaglandin E2, 5,6-dihydro-prostaglandin I2, 6-ketoprostaglandin F1α, 15-hydroxy-9α,11α (epoxymethano)prosta-5,13-dienoic acid and 15-hydroxy-11α,9α(epoxymethano)prosta-5,13-dienoic acid
Prostaglandins and Medicine
(1979) - et al.
Thromboxanes : a new group of biologically active components derived from prostaglandin endoperoxides
There are more references available in the full text version of this article.
Cited by (0)
Copyright © 1982 Published by Elsevier Ireland Ltd.